These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The metabolic syndrome - an ongoing story. Duvnjak L; Duvnjak M J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():19-24. PubMed ID: 20388942 [TBL] [Abstract][Full Text] [Related]
23. Hypertension as part of the metabolic syndrome. Cheung B J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of hypertension in the cardiometabolic syndrome. Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221 [TBL] [Abstract][Full Text] [Related]
25. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development]. Kieć-Klimczak M; Malczewska-Malec M; Huszno B Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676 [TBL] [Abstract][Full Text] [Related]
26. Hypertension, insulin resistance, and the metabolic syndrome. Natali A; Ferrannini E Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527 [TBL] [Abstract][Full Text] [Related]
27. Leptin and the regulation of endothelial function in physiological and pathological conditions. Bełtowski J Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):168-78. PubMed ID: 21973116 [TBL] [Abstract][Full Text] [Related]
28. Obesity and the metabolic syndrome in the elderly--a mini-review. Lechleitner M Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025 [TBL] [Abstract][Full Text] [Related]
30. Experimental rat models to study the metabolic syndrome. Aleixandre de Artiñano A; Miguel Castro M Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025 [TBL] [Abstract][Full Text] [Related]
31. [Adipocytokins, obesity and development of type 2 diabetes]. Lacquemant C; Vasseur F; Leprêtre F; Froguel P Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899 [TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Tkác I Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S2-9. PubMed ID: 15955370 [TBL] [Abstract][Full Text] [Related]
34. Sympathetic system activity in obesity and metabolic syndrome. Tentolouris N; Liatis S; Katsilambros N Ann N Y Acad Sci; 2006 Nov; 1083():129-52. PubMed ID: 17148737 [TBL] [Abstract][Full Text] [Related]
36. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Grassi G Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783 [TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459 [TBL] [Abstract][Full Text] [Related]
38. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890 [TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome in women. Schneider JG; Tompkins C; Blumenthal RS; Mora S Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375 [TBL] [Abstract][Full Text] [Related]